Category: Infectious

Equine Herpesvirus-1 (EHV-1) is one of the most serious infectious diseases facing horse owners today. This highly contagious virus spreads rapidly through horse populations and can cause significant illness, reproductive loss, and in severe cases, neurological complications and death. Understanding EHV-1 outbreaks is essential for anyone who owns, manages, or cares for horses, particularly those operating boarding facilities or managing herds with multiple animals. While EHV-1 has been endemic in the equine population for decades, periodic outbreaks serve as stark reminders of how quickly this virus can spread and the importance of biosecurity measures on any equine property.

This article provides horse owners and caretakers with practical, evidence-based information about EHV-1 outbreaks, including how the virus spreads, the clinical signs to recognize, quarantine and management strategies, and vaccination protocols. The information presented here is educational and does not replace consultation with a licensed equine veterinarian. For urgent symptoms such as fever above 105 degrees Fahrenheit, severe neurological signs, or acute respiratory distress, contact an equine veterinarian immediately.

What is EHV-1 and Why Does It Cause Outbreaks?

Equine Herpesvirus-1 is a double-stranded DNA virus that belongs to the herpesvirus family. It is closely related to EHV-4, another equine herpesvirus, but EHV-1 is generally considered more virulent and pathogenic. The virus is endemic worldwide and affects horses of all ages and breeds, though young horses (under 3 years), pregnant mares, and immunocompromised animals are at higher risk for severe disease.

EHV-1 spreads through respiratory secretions, nasal discharge, saliva, urine, feces, and aborted fetal tissue. The virus can also be transmitted via contaminated equipment, clothing, vehicles, and hands. An infected horse may shed the virus for 7 to 10 days during the acute respiratory phase, but the virus can remain latent in nerve tissue and reactivate later, particularly during stress. This latency and reactivation cycle makes EHV-1 difficult to eliminate from a herd and a primary reason why outbreaks can recur unexpectedly.

Clinical Signs of EHV-1 Infection

Respiratory Disease

The most common presentation of EHV-1 is respiratory disease. Infected horses typically develop fever, often reaching 104 to 107 degrees Fahrenheit, within 1 to 3 days of exposure. Other early signs include nasal discharge (which may be clear or mucopurulent), coughing, depression, loss of appetite, and enlarged lymph nodes in the head and neck. Respiratory signs usually peak within 7 to 10 days and may resolve within 2 to 3 weeks, though secondary bacterial infections can complicate recovery and prolong illness.

Reproductive Disease

In pregnant mares, EHV-1 can cause abortion, typically in the third trimester but sometimes earlier. Abortions associated with EHV-1 may occur with or without preceding respiratory signs, sometimes weeks after initial infection. Aborted fetuses and placental tissue are highly infectious and represent a major biosecurity hazard. Mares may also experience retention of fetal membranes or secondary uterine infections following abortion.

Neurological Disease (EHV-1 Myeloencephalopathy)

A concerning manifestation of EHV-1 is neurological disease, referred to as EHV-1 myeloencephalopathy (EHM). This form occurs in approximately 1 to 10 percent of EHV-1 infections and results from viral invasion of the central nervous system. Clinical signs develop acutely and may include hind limb ataxia (incoordination), weakness, urinary retention, fecal incontinence, loss of tail tone, and in severe cases, recumbency (inability to stand). Neurological signs can appear with or without respiratory signs, making diagnosis challenging. The prognosis varies; some horses recover fully, while others experience permanent neurological deficits or die.

Recognition and Diagnosis of an EHV-1 Outbreak

An EHV-1 outbreak is typically recognized when multiple horses at a facility develop fever, respiratory signs, or other clinical signs consistent with the virus within a short time frame. On a boarding facility or breeding operation with 20 to 40 horses, an outbreak may affect 10 to 30 percent of the herd within 2 to 4 weeks if biosecurity measures are not implemented immediately.

Diagnosis is confirmed through nasopharyngeal or nasal swab samples tested via polymerase chain reaction (PCR) or virus isolation, blood serum PCRs, or aborted fetal tissue testing. A veterinarian may also use clinical signs, herd history, and bloodwork to support a presumptive diagnosis. Testing should begin as soon as EHV-1 is suspected, as early confirmation allows for rapid implementation of quarantine protocols.

Quarantine and Management During an Outbreak

Once EHV-1 is confirmed or strongly suspected, strict quarantine measures must be implemented immediately to prevent spread to other horses on the property and to neighboring facilities.

Essential Quarantine Protocols

• Isolate affected horses: Move sick or confirmed positive horses to a separate barn or paddock area at least 100 feet away from other horses, with separate fencing if possible.
• Restrict movement: Do not move horses on or off the property except for emergency veterinary care.
• Dedicated staff and equipment: Assign specific caretakers to handle quarantined horses, and keep all equipment, feed buckets, grooming supplies, and tack separate.
• Hand hygiene: Wash hands thoroughly and change clothing after handling affected horses or entering quarantine areas.
• Disinfection: Clean and disinfect equipment, gates, water troughs, and any shared surfaces with a quaternary ammonium-based disinfectant or 10 percent bleach solution.
• Monitor unexposed horses: Take daily temperatures on all other horses and watch for clinical signs. Quarantine any new horses showing signs.
• Coordinate with neighbors: Notify boarding facilities and farms within a few miles to alert them to the outbreak, allowing them to heighten biosecurity.

Treatment and Supportive Care

No specific antiviral treatment exists for EHV-1 in horses. Management focuses on supportive care: stall rest, pain relief, febrifuges (fever reducers) such as phenylbutazone or firocoxib, and monitoring for secondary complications. Horses with respiratory disease benefit from good ventilation, clean water, and high-quality forage. Horses showing neurological signs require careful nursing, frequent recumbent horse turns if bedbound, and assessment for urinary or fecal retention. In severe cases, hospitalization at an equine clinic may be necessary.

Duration of Quarantine and Return to Normal

The quarantine period depends on the situation. For individual confirmed cases, quarantine is typically maintained for a minimum of 7 to 14 days after the horse has recovered and shown no fever for at least 48 hours. For facility outbreaks, quarantine may last 3 to 4 weeks after the last new case appears. Some veterinarians recommend extended quarantine periods (up to 4 to 6 weeks) due to the risk of viral shedding and latent reactivation.

Before lifting quarantine, work with your veterinarian to confirm that affected horses are clinically normal, have been afebrile for at least 2 days, and show no respiratory or other signs. Grazing isolation (separate pasture) for an additional week or two provides an extra safety margin.

Vaccination Against EHV-1

Vaccine Types and Efficacy

Several EHV-1 vaccines are available, including inactivated whole-virus vaccines and modified-live vaccines. Most commonly, vaccines are components of combination products that also protect against EHV-4 and other equine respiratory viruses. Vaccination does not prevent infection entirely but significantly reduces the severity of respiratory disease, lowers fever, and reduces viral shedding. Vaccines are less effective at preventing abortion or neurological disease, underscoring the importance of biosecurity.

Vaccination Recommendations

The American Association of Equine Practitioners (AAEP) recommends annual vaccination of horses with EHV-1/EHV-4 combination vaccines as part of a core vaccination program. Breeding mares should be vaccinated at specific times during pregnancy (typically during the 5th, 7th, and 9th months of gestation) to reduce the risk of abortion. Young horses should begin the vaccine series at 4 to 6 months of age with boosters every 4 to 6 weeks until 1 year of age, then annually.

Horses at high risk, including those at boarding facilities, breeding operations, or show facilities, may benefit from more frequent boosters (every 6 months). However, vaccination during an active outbreak is not recommended, as the immune response may be compromised in actively infected animals.

Preventing EHV-1 Outbreaks: Biosecurity Strategies

Prevention is far more effective than managing an outbreak. Implement the following biosecurity measures year-round:

• Vaccinate all horses annually against EHV-1/EHV-4 and maintain booster schedules.
• Quarantine new arrivals for 2 to 3 weeks before introducing them to the main herd, monitoring for fever and respiratory signs daily.
• Minimize horse movement to shows, sales, and other facilities, and isolate returning horses for 2 to 3 weeks.
• Maintain separate equipment, feed buckets, and grooming supplies for each horse when possible.
• Practice rigorous hand and boot hygiene, especially when handling multiple horses.
• Clean and disinfect water troughs, feeders, and common areas regularly.
• Maintain good ventilation in barns and avoid overcrowding.
• Work with your veterinarian to establish an outbreak response plan before one occurs.

Special Considerations: Neurological Cases and Abortion

Horses with EHV-1 myeloencephalopathy require intensive nursing and may need months of recovery. Work closely with an equine veterinary neurologist or internist for diagnosis (such as cerebrospinal fluid analysis) and treatment protocols. Recovery is unpredictable; some horses regain full function, while others may not.

Aborted fetuses and placental tissue must be handled as highly infectious biohazard material. Use gloves and a mask when handling, and consult your veterinarian on safe disposal methods. Do not allow other horses to contact aborted material.

Reporting and Legal Considerations

EHV-1 outbreaks, particularly those with neurological or reproductive involvement, should be reported to your state or local animal health authority or veterinary board. Facilities operating boarding, breeding, or show operations may be required to report outbreaks. Transparency and cooperation with authorities protect the wider equine community and demonstrate responsible management.

Frequently Asked Questions

How long does EHV-1 immunity last after vaccination?

Vaccination-induced immunity wanes over 6 to 12 months, which is why annual boosters are recommended. Immunity is improved in horses that have been both vaccinated and previously exposed to the virus, though prior exposure alone (without vaccination) does not provide reliable protection against severe disease.

Can humans catch EHV-1 from horses?

No, EHV-1 does not infect humans. However, humans can carry the virus on hands, clothing, and equipment, making hand hygiene and equipment sanitation critical during outbreaks.

Is it safe to ride a horse recovering from EHV-1?

Most horses recovering from uncomplicated respiratory EHV-1 can resume light work within 3 to 4 weeks, once fever has resolved and they are eating and breathing normally. Horses recovering from neurological disease should not be ridden until they have regained full coordination and strength, which may take weeks to months. Always consult your veterinarian before returning to work.

What is the mortality rate of EHV-1?

Overall mortality from EHV-1 respiratory disease is low, typically less than 5 percent in adult horses with appropriate supportive care. However, mortality rises in young foals, immunocompromised horses, and cases complicated by severe secondary infections or neurological disease, where mortality may reach 10 to 15 percent or higher.

Key Takeaways

• EHV-1 is a highly contagious virus causing respiratory disease, abortion, and neurological disease (EHM) in horses of all ages.
• The virus spreads via respiratory secretions and fecal-oral contact; strict quarantine and biosecurity are essential during outbreaks.
• Clinical signs include fever, nasal discharge, cough, depression, and in severe cases, hind limb weakness and ataxia.
• Diagnosis is confirmed by PCR testing of nasal swabs, blood, or fetal tissue; suspected cases should be isolated immediately.
• Treatment is supportive; no specific antiviral exists. Quarantine typically lasts 2 to 6 weeks depending on herd impact.
• Annual EHV-1/EHV-4 vaccination, strategic booster schedules for high-risk horses, and comprehensive biosecurity measures are the foundation of prevention.
• Pregnant mares should receive booster vaccinations during the 5th, 7th, and 9th months of pregnancy to reduce abortion risk.
• Consult an equine veterinarian immediately for fever above 105 degrees, respiratory distress, neurological signs, or abortion on your property.

Tetanus is a serious and often fatal disease in horses caused by the bacterium Clostridium tetani. This pathogen produces a powerful neurotoxin that affects the nervous system, leading to severe muscle rigidity and loss of motor control. While tetanus is preventable through proper vaccination and management practices, it remains a significant health threat for horses of all ages and types. Understanding the signs, prevention strategies, and emergency response protocols is essential for every horse owner and caregiver.

The good news is that tetanus is highly preventable with routine vaccination. However, unvaccinated or under-vaccinated horses face serious risk, and even vaccinated horses can develop tetanus if they suffer contaminated wounds. Because tetanus can develop rapidly and has a high mortality rate—often 50 to 80 percent in untreated cases—early recognition and immediate veterinary intervention are critical. This article provides comprehensive information about tetanus prevention, clinical signs, and management, though it is not a substitute for professional veterinary diagnosis or treatment.

What Is Tetanus and How Do Horses Get It

Tetanus is caused by Clostridium tetani, an anaerobic bacterium found in soil, dust, and feces worldwide. The bacterium itself is not dangerous; the problem lies in the toxin it produces when it grows in oxygen-poor environments. Horses contract tetanus when C. tetani spores enter the body through a wound and begin to multiply in an anaerobic (oxygen-free) space.

Common entry points include:

• Puncture wounds, especially to the foot or sole (stepping on a nail, sharp objects in pasture)
• Deep lacerations or cuts with contaminated soil exposure
• Surgical wounds or castration sites
• Dental infections or tooth extractions
• Umbilical cord infections in foals
• Injection sites with poor sterile technique
• Chronic wounds or abscesses that create anaerobic pockets

Tetanus can also develop after seemingly minor injuries that go unnoticed or are not properly cleaned and treated. The incubation period—the time between infection and the appearance of clinical signs—ranges from 1 to 3 weeks, though it can occasionally be shorter or longer. This delay means a horse may have contracted tetanus before obvious symptoms appear.

Clinical Signs of Tetanus in Horses

The signs of tetanus reflect the toxin’s effect on the nervous system. Affected horses experience progressive muscle stiffness and rigidity, beginning with the muscles closest to the infection site and spreading throughout the body. Horse owners should be alert for the following signs:

Early Signs

• Stiffness or difficulty moving, especially after exercise or rest
• Reluctance to eat or chewing difficulties
• Jaw stiffness or “lockjaw” (trismus)
• Elevated third eyelid (nictitating membrane) drawing up over the eye
• Ears held stiffly or pointed backward
• Flared nostrils
• Anxiety or muscle tremors

Progressive Signs

• Severe muscle rigidity throughout the body
• Inability to open the mouth fully
• Difficulty swallowing
• Rigid posture with legs held stiffly (“sawhorse stance”)
• Inability or extreme difficulty lying down
• Excessive salivation
• Prolapse of the third eyelid
• Sweating
• Increased heart rate and respiratory rate
• Seizures or violent muscle spasms in severe cases

As the disease progresses, affected horses may become recumbent (unable to stand) and lose the ability to eat and drink. Without treatment, respiratory failure or complications such as aspiration pneumonia often occur. If you observe signs consistent with tetanus, contact your equine veterinarian immediately.

Diagnosis of Tetanus

Tetanus is diagnosed primarily through clinical signs rather than laboratory tests. A veterinarian will perform a physical examination and review the horse’s vaccination history and recent wound exposure. There is no definitive blood test for active tetanus infection; diagnosis is clinical and based on the characteristic muscle rigidity and nervous system signs.

The veterinarian will also search for an entry wound or infection site, which may help confirm the diagnosis and guide treatment. In some cases, the source wound may already be healing or difficult to locate, particularly if the infection developed from a puncture wound or internal infection.

Treatment and Management

Tetanus is a medical emergency requiring immediate hospitalization and intensive supportive care. Unfortunately, there is no cure that eliminates the toxin already in the nervous system; treatment focuses on stopping bacterial growth, providing supportive care, and managing symptoms while the body gradually eliminates the toxin.

Veterinary Treatment Options

• Antibiotics: High-dose penicillin (typically 20,000 to 40,000 units per kilogram intravenously every 4 to 6 hours) is the standard antibiotic choice. Metronidazole may also be used to target anaerobic bacteria. Antibiotics are continued for 7 to 10 days or longer.
• Tetanus Antitoxin: Equine tetanus antitoxin (TTA) or human tetanus immunoglobulin (TIG) may be administered to neutralize circulating toxin, though effectiveness is limited once toxin has bound to nerve tissue.
• Supportive Care: Hospitalized horses require 24-hour nursing care including IV fluids, pain management, anti-inflammatory medications, and monitoring of vital signs.
• Wound Care: Any identified source wound is thoroughly cleaned, debrided, and treated to eliminate bacterial growth.
• Nutritional Support: Many horses with tetanus cannot eat or drink normally and require nasogastric tube feeding and water supplementation.
• Muscle Relaxants and Sedation: Drugs such as diazepam or other muscle relaxants may be used to reduce muscle spasms and rigidity.
• Environmental Management: Hospitalized horses are kept in a quiet, dark, stress-free environment to minimize external stimuli that can trigger violent muscle spasms.

Recovery from tetanus, when it occurs, is slow. Horses that survive may require weeks to months of nursing care and rehabilitation. The mortality rate even with aggressive treatment remains high, typically 50 to 80 percent, depending on the severity at diagnosis and the horse’s overall health status.

Prevention: Vaccination Is Key

Vaccination is the most effective way to prevent tetanus. The tetanus toxoid vaccine is highly effective and is considered a core vaccine for all horses, regardless of age or use.

Vaccination Recommendations

Horse Category	Initial Vaccination	Booster Schedule
Foals	First dose at 3 to 6 months; second dose 4 weeks later	Annual boosters; every 1 to 3 years after adult schedule established
Adult horses (previously vaccinated)	Two doses, 4 weeks apart, if vaccination history unknown	Annual or every 3 years depending on risk and regional recommendations
Adult horses (prior vaccination documented)	Not needed	Annual booster (may extend to every 3 years with veterinarian approval)
Pregnant mares	Booster at 4 to 6 weeks before foaling	Annual or every 3 years; booster before each pregnancy

Most equine veterinarians recommend annual tetanus boosters, though recent research suggests that some horses with documented prior vaccination may be protected for up to 3 years. Always follow your veterinarian’s specific recommendations based on your horse’s age, vaccination history, risk exposure, and regional disease prevalence.

Post-Wound Vaccination

If a horse sustains a wound and has not been vaccinated within the past 6 to 12 months, or if vaccination history is unknown, an immediate tetanus booster is recommended. The booster should ideally be given within 24 hours of the wound for maximum protection. Additionally, the wound should be thoroughly cleaned and debrided to remove soil and contaminated tissue.

Wound Care and Management

Proper wound care is the second line of defense against tetanus. Every wound, no matter how small it appears, should be treated with attention to reducing tetanus risk:

• Clean immediately: Flush the wound with clean running water or sterile saline to remove soil, debris, and bacteria.
• Assess depth: Puncture wounds and deep lacerations carry higher tetanus risk than superficial abrasions.
• Debride damaged tissue: Remove dirt, dead tissue, and contaminated material; this may require veterinary intervention.
• Do not close puncture wounds: Leave puncture wounds open to allow drainage and aeration, reducing the anaerobic environment where C. tetani thrives.
• Apply topical treatment: Use an antiseptic spray or ointment and monitor the wound daily for signs of infection.
• Consider professional wound closure: Deep lacerations may require veterinary assessment for proper closure after cleaning.
• Monitor for infection: Watch for swelling, discharge, heat, or lameness in the following days and weeks.

Never assume a wound is too minor to warrant attention. Many tetanus cases in horses have originated from small puncture wounds that seemed insignificant at the time.

Frequently Asked Questions

Can a vaccinated horse still get tetanus?

Yes, though it is rare. A fully vaccinated horse has strong protection, but immunity is not absolute. Horses with documented prior tetanus vaccination have approximately 95 percent protection; however, incomplete vaccination, extremely old prior vaccination, or very high bacterial contamination in a wound can occasionally lead to breakthrough cases. This is why booster vaccination after a wound is still recommended for all horses, regardless of prior vaccination status.

How long does a tetanus vaccine last?

After an initial series of two doses given 4 weeks apart, tetanus toxoid protection typically lasts 1 to 3 years, depending on the individual horse and the vaccine formulation used. Most veterinarians recommend annual boosters to maintain optimal protection. Pregnant mares receive a booster 4 to 6 weeks before foaling to maximize antibodies transferred to the foal via colostrum.

What should I do if my horse has a puncture wound?

Immediately contact your equine veterinarian. Clean the wound with running water and do not allow it to close or scab over if possible. Provide a booster tetanus vaccination if the horse’s vaccination status is current within 6 to 12 months; if not, vaccinate immediately. The veterinarian may recommend soaking the foot in warm salt water, tetanus antitoxin injection, and antibiotics depending on the wound’s severity and location.

Is tetanus contagious between horses?

No. Tetanus is not transmitted from horse to horse. It is acquired only through contaminated wounds and soil exposure. Caring for a horse with tetanus does not put other horses at risk, though good hygiene practices should always be maintained.

Key Takeaways

• Tetanus is a serious, often fatal disease caused by Clostridium tetani bacteria, acquired through contaminated wounds in soil or feces.
• Clinical signs include progressive muscle stiffness, jaw stiffness, elevated third eyelid, and a characteristic “sawhorse stance” as rigidity advances.
• Tetanus is a medical emergency; contact your equine veterinarian immediately if tetanus is suspected. Early hospitalization and intensive supportive care are essential.
• Vaccination with tetanus toxoid is highly effective and is the best prevention; all horses should receive an initial series followed by annual or every-3-year boosters depending on risk and veterinary recommendation.
• Proper wound care—including thorough cleaning, leaving puncture wounds open to air, and vaccination booster within 24 hours of injury—significantly reduces tetanus risk.
• Even with aggressive veterinary treatment, the mortality rate for tetanus remains high at 50 to 80 percent; prevention through vaccination is far more effective than treatment.
• Tetanus is not contagious between horses, so affected horses pose no risk to other animals, though they require intensive individual care and isolation in a quiet environment.

Wounds that introduce Clostridium tetani can also introduce other soil-borne pathogens. Pigeon fever, caused by Corynebacterium pseudotuberculosis, is another bacterial infection that commonly enters through skin abrasions and wounds.